Exact Mass: 401.2274
Exact Mass Matches: 401.2274
Found 500 metabolites which its exact mass value is equals to given mass value 401.2274
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Evogliptin
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
6'-Hydroxybuspirone
6-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
Buspirone N-oxide
Buspirone N-oxide is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
3'-Hydroxybuspirone
3-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
5-Hydroxybuspirone
5-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
5-Methylurapidil
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Isoquinoline, 1,2,3,4-tetrahydro-2-(4-amino-6-((4-phenyl-1-piperazinyl)methyl)-s-triazin-2-yl)-
Amperozide
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Amperozide is an atypical antipsychotic that acts as an antagonist of the 5-HT2 receptor with a Ki value of 26 nM. Amperozide has a low affinity for D2 receptors[1].
Evogliptin
[2-Amino-2-(hydroxymethyl)-5-(4-octylphenyl)pentyl] dihydrogen phosphate
N-Allm
1,4-Bis(4-methoxyphenyl)-3-(3-phenylpropyl)-2-azetidinone
(3E,9E)-5-Hydroxy-14-isobutyl-9,12,13-trimethyl-6,7,8,10a,13,13a,14,15-octahydro-2H-oxacyclododecino[2,3-d]isoindole-2,16(5H)-dione
3-(1-(cyclohexylmethyl)-1h-indazole-3-carboxamido)-2,2-dimethylsuccinic acid
(2R,3S,4aS,7R,8R,8aS)-2,3,4-trihydroxy-4,4,7,8a-tetramethylspiro[2,3,4a,5,6,7-hexahydro-1H-naphthalene-8,2-7,8-dihydro-3H-furo[2,3-e]isoindole]-6-one
1-Methoxy-3-[3,5-dimethyl-6-[1-(hydroxymethyl)propyl]tetrahydro-2H-pyran-2-yl]-4-hydroxy-5-phenyl-1,2-dihydropyridine-2-one
Hexanoic acid, 2-((phenylamino)carbonyl)-, 1,2-diphenylhydrazide
1-Methoxy-3-[3,5-dimethyl-6-(1-methyl-3-hydroxypropyl)tetrahydro-2H-pyran-2-yl]-4-hydroxy-5-phenylpyridine-2(1H)-one
C23H31NO5_(2R,2R,4aS,6S,7R,8aS)-4,6,7-Trihydroxy-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,7,8,8,8a-decahydro-2H-spiro[furo[2,3-e]isoindole-2,1-naphthalen]-6(3H)-one
C24H35NO4_1H-Cycloundec[d]isoindole-1,15(2H)-dione, 3,3a,4,6a,9,10,11,12-octahydro-11,12-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-, (7E,13E)
C24H35NO4_(1S,2R,3R,6S,7R,8S,11S,14S,15S,18R)-18-Hydroxy-8-isobutyl-5,6,15-trimethyl-19-oxa-9-azapentacyclo[13.3.1.0~2,14~.0~3,11~.0~7,11~]nonadec-4-ene-10,12-dione
6-hydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-2H,5H,6H,7H,8H,13H,13aH,14H,15H,16H,16bH-oxacyclododeca[3,2-e]isoindole-2,16-dione
Ala Ala Ile Gln
Ala Ala Leu Gln
Ala Ala Gln Ile
Ala Ala Gln Leu
Ala Gly Arg Val
Ala Gly Val Arg
Ala Ile Ala Gln
Ala Ile Gln Ala
Ala Lys Pro Ser
Ala Lys Ser Pro
Ala Leu Ala Gln
Ala Leu Gln Ala
Ala Asn Pro Thr
Ala Asn Thr Pro
Ala Asn Val Val
Ala Pro Lys Ser
Ala Pro Asn Thr
Ala Pro Gln Ser
Ala Pro Ser Lys
Ala Pro Ser Gln
Ala Pro Thr Asn
Ala Gln Ala Ile
Ala Gln Ala Leu
Ala Gln Ile Ala
Ala Gln Leu Ala
Ala Gln Pro Ser
Ala Gln Ser Pro
Ala Arg Gly Val
Ala Arg Val Gly
Ala Ser Lys Pro
Ala Ser Pro Lys
Ala Ser Pro Gln
Ala Ser Gln Pro
Ala Thr Asn Pro
Ala Thr Pro Asn
Ala Val Gly Arg
Ala Val Asn Val
Ala Val Arg Gly
Ala Val Val Asn
Gly Ala Arg Val
Gly Ala Val Arg
Gly Gly Ile Arg
Gly Gly Leu Arg
Gly Gly Arg Ile
Gly Gly Arg Leu
Gly Ile Gly Arg
Gly Ile Asn Val
Gly Ile Arg Gly
Gly Ile Val Asn
Gly Lys Pro Thr
Gly Lys Thr Pro
Gly Leu Gly Arg
Gly Leu Asn Val
Gly Leu Arg Gly
Gly Leu Val Asn
Gly Asn Ile Val
Gly Asn Leu Val
Gly Asn Val Ile
Gly Asn Val Leu
Gly Pro Lys Thr
Gly Pro Gln Thr
Gly Pro Thr Lys
Gly Pro Thr Gln
Gly Gln Pro Thr
Gly Gln Thr Pro
Gly Gln Val Val
Gly Arg Ala Val
Gly Arg Gly Ile
Gly Arg Gly Leu
Gly Arg Ile Gly
Gly Arg Leu Gly
Gly Arg Val Ala
Gly Thr Lys Pro
Gly Thr Pro Lys
Gly Thr Pro Gln
Gly Thr Gln Pro
Gly Val Ala Arg
Gly Val Ile Asn
Gly Val Leu Asn
Gly Val Asn Ile
Gly Val Asn Leu
Gly Val Gln Val
Gly Val Arg Ala
Gly Val Val Gln
Ile Ala Ala Gln
Ile Ala Gln Ala
Ile Gly Gly Arg
Ile Gly Asn Val
Ile Gly Arg Gly
Ile Gly Val Asn
Ile Asn Gly Val
Ile Asn Val Gly
Ile Gln Ala Ala
Ile Arg Gly Gly
Ile Val Gly Asn
Ile Val Asn Gly
Lys Ala Pro Ser
Lys Ala Ser Pro
Lys Gly Pro Thr
Lys Gly Thr Pro
Lys Pro Ala Ser
Lys Pro Gly Thr
Lys Pro Ser Ala
Lys Pro Thr Gly
Lys Ser Ala Pro
Lys Ser Pro Ala
Lys Thr Gly Pro
Lys Thr Pro Gly
Leu Ala Ala Gln
Leu Ala Gln Ala
Leu Gly Gly Arg
Leu Gly Asn Val
Leu Gly Arg Gly
Leu Gly Val Asn
Leu Asn Gly Val
Leu Asn Val Gly
Leu Gln Ala Ala
Leu Arg Gly Gly
Leu Val Gly Asn
Leu Val Asn Gly
Asn Ala Pro Thr
Asn Ala Thr Pro
Asn Ala Val Val
Asn Gly Ile Val
Asn Gly Leu Val
Asn Gly Val Ile
Asn Gly Val Leu
Asn Ile Gly Val
Asn Ile Val Gly
Asn Leu Gly Val
Asn Leu Val Gly
Asn Pro Ala Thr
Asn Pro Thr Ala
Asn Thr Ala Pro
Asn Thr Pro Ala
Asn Val Ala Val
Asn Val Gly Ile
Asn Val Gly Leu
Asn Val Ile Gly
Asn Val Leu Gly
Asn Val Val Ala
Pro Ala Lys Ser
Pro Ala Asn Thr
Pro Ala Gln Ser
Pro Ala Ser Lys
Pro Ala Ser Gln
Pro Gly Lys Thr
Pro Gly Thr Lys
Pro Lys Ala Ser
Pro Lys Gly Thr
Pro Lys Ser Ala
Pro Lys Thr Gly
Pro Ser Ala Lys
Pro Ser Lys Ala
Pro Thr Gly Lys
Pro Thr Lys Gly
Gln Ala Ala Ile
Gln Ala Ala Leu
Gln Ala Ile Ala
Gln Ala Leu Ala
Gln Gly Val Val
Gln Ile Ala Ala
Gln Leu Ala Ala
Gln Val Gly Val
Gln Val Val Gly
Arg Ala Gly Val
Arg Ala Val Gly
Arg Gly Ala Val
Arg Gly Gly Ile
Arg Gly Gly Leu
Arg Gly Ile Gly
Arg Gly Leu Gly
Arg Gly Val Ala
Arg Ile Gly Gly
Arg Leu Gly Gly
Arg Val Ala Gly
Arg Val Gly Ala
Ser Ala Lys Pro
Ser Ala Pro Lys
Ser Lys Ala Pro
Ser Lys Pro Ala
Ser Pro Ala Lys
Ser Pro Lys Ala
Thr Gly Lys Pro
Thr Gly Pro Lys
Thr Lys Gly Pro
Thr Lys Pro Gly
Thr Pro Gly Lys
Thr Pro Lys Gly
Val Ala Gly Arg
Val Ala Asn Val
Val Ala Arg Gly
Val Ala Val Asn
Val Gly Ala Arg
Val Gly Ile Asn
Val Gly Leu Asn
Val Gly Asn Ile
Val Gly Asn Leu
Val Gly Gln Val
Val Gly Arg Ala
Val Gly Val Gln
Val Ile Gly Asn
Val Ile Asn Gly
Val Leu Gly Asn
Val Leu Asn Gly
Val Asn Ala Val
Val Asn Gly Ile
Val Asn Gly Leu
Val Asn Ile Gly
Val Asn Leu Gly
Val Asn Val Ala
Val Gln Gly Val
Val Gln Val Gly
Val Arg Ala Gly
Val Arg Gly Ala
Val Val Ala Asn
Val Val Gly Gln
Val Val Asn Ala
Val Val Gln Gly
Pyrilamine maleate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Mepyramine maleate, a first generation antihistamine, is an antagonist of histamine H1 receptor, with Kds of 0.8 nM, 5200 nM and >3000 nM for H1, H2, and H3 receptor, respectively, and a pKd of 9.4 for H1 receptor.
p-dodecylbenzenesulphonic acid, compound with 1-aminopropan-2-ol (1:1)
1-tert-Butyl 7-methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1,7-dicarboxylate
biperiden lactate
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
4-Hydroxy-alpha1-[[[6-(3-phenylpropoxy)hexyl]amino]methyl]-1,3-benzenedimethanol
(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-cyclohexylpyrrolidine-1-carboxamide
ALLM (Calpain Inhibitor)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins
4-(HYDROXY-DIPHENYL-METHYL)-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER
[[1-[N-Hydroxy-acetamidyl]-3-methyl-butyl]-carbonyl-leucinyl]-alanine ethyl ester
4-(3,4-dihydro-2H-quinolin-1-yl)-6-[(4-phenyl-1-piperazinyl)methyl]-1,3,5-triazin-2-amine
2-[3-[[2-oxo-2-(1-pyrrolidinyl)ethyl]thio]-1-indolyl]-N,N-di(propan-2-yl)acetamide
4-(6-{[(4-Methylcyclohexyl)amino]methyl}-1,4-Dihydroindeno[1,2-C]pyrazol-3-Yl)benzoic Acid
6-[Hydroxyimino-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphtalen-2-YL)-methyl]-naphtalene-2-carboxylic acid
Dehydrocholate
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Acrichine
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
ALLM
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors
[1-(3-Phenoxypropyl)-4-piperidinyl]-diphenylmethanol
1-ethyl-4-hydroxy-2-oxo-N-(1-oxodecyl)-3-quinolinecarbohydrazide
(3E,9E)-5,6-Dihydroxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-triene-2,18-dione
(1S,2R,3R,6S,7R,8S,11S,14S,15S,18R)-18-hydroxy-5,6,15-trimethyl-8-(2-methylpropyl)-19-oxa-9-azapentacyclo[13.3.1.02,14.03,11.07,11]nonadec-4-ene-10,12-dione
3-(4-Methoxyphenyl)-8-(6-methyl-2-phenyl-4-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol
5,6-dimethyl-2-[1-[[1-(phenylmethyl)-5-tetrazolyl]methyl]-4-piperidinyl]-1H-benzimidazole
7-(4-Ethyl-1-piperazinyl)-2-(3-fluorophenyl)-5-phenylpyrazolo[1,5-a]pyrimidine
1-[2-[[(2,3-dihydro-1H-inden-5-ylamino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester
Crambescidin 401
An organic heteropentacyclic guanidine alkaloid isolated from the marine sponge Crambe crambe.
(1S,5R)-3-[(3,5-dimethoxyphenyl)methyl]-7-(4-pyridin-4-ylphenyl)-3,6-diazabicyclo[3.1.1]heptane
3-[(3aS,4S,9bR)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
4-[(3aR,4R,9bR)-1-[cyclopentyl(oxo)methyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]benzonitrile
(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
2-[(2S,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
2-[(2S,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
(2R,3S)-2-[(dimethylamino)methyl]-8-(4-fluorophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
2-[(2S,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
2-[(2R,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
2-[(2R,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
2-[(2R,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
2-[(2S,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
2-[(2R,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
1-[(1R,2aS,8bS)-2-[(2,5-difluorophenyl)methyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-2-(dimethylamino)ethanone
3-[(3aR,4S,9bS)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
3-[(3aR,4R,9bS)-1-(2-cyclopropyl-1-oxoethyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile
15-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxopentadecanoate
(14R)-14-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxopentadecanoate
(3Z,9Z)-5,6-dihydroxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-3,9,12-triene-2,18-dione
Amperozide
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Amperozide is an atypical antipsychotic that acts as an antagonist of the 5-HT2 receptor with a Ki value of 26 nM. Amperozide has a low affinity for D2 receptors[1].
11-O-demethyl-17-O-deacetylvindolinium(1+)
The conjugate acid of 11-O-demethyl-17-O-deacetylvindoline arising from protonation of the tertiary amino group; major species at pH 7.3.
Ro 64-6198
Ro 64-6198 is a potent, selective, nonpeptide, high-affinity, high cellular permeability and brain penetration N/OFQ receptor (NOP) agonist with an EC50 value of 25.6 nM. Ro 64-6198 is at least 100 times more selective for the NOP receptor over the classic opioid receptors. Ro 64-6198 can be used for stress and anxiety, addiction, neuropathic pain, cough, and anorexia[1][2].
(1'r,2s,2's,4's,8'r,9's,13's,16's,18's)-16'-amino-9',13'-dimethyl-5'-oxaspiro[oxolane-2,7'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-5,6'-dione
methyl (1r,3r,4r,10s,14r,15s,19s)-15,19-dihydroxy-18-(hydroxymethyl)-14-methyl-12-azahexacyclo[10.6.1.1¹,⁴.0¹⁰,¹⁸.0¹⁵,¹⁹.0⁷,²⁰]icosa-7(20),16-diene-3-carboxylate
1,11,12-trihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h-cycloundeca[d]isoindol-15-one
(5s,10as,13s,13as,14s,16ar)-5,16-dihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[3,2-d]isoindol-2-one
(1r,2s,3s,6r,7s,8r,11s,14r,15r,16s)-10,16-dihydroxy-1,5,6-trimethyl-8-(2-methylpropyl)-19-oxa-9-azapentacyclo[13.3.1.0²,¹⁴.0³,¹¹.0⁷,¹¹]nonadeca-4,9-dien-12-one
(1r,2r,4s,5r,7r,8r,9r,10r,13r,16s,17r)-11-ethyl-7,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-4-yl acetate
(3s,6s)-3-benzyl-6-{[1-(3-methylbut-2-en-1-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol
(2r,2'r,4'as,5'r,6'r,8'as)-5'-(hydroxymethyl)-2',5',8'a-trimethyl-3,3',4',4'a,6',7',8,8'-octahydro-2'h-spiro[furo[2,3-e]isoindole-2,1'-naphthalene]-4,6,6'-triol
(3s,3ar,4s,6ar,13r,15ar)-1,13-dihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,13h,14h-cycloundeca[d]isoindole-12,15-dione
(2s)-2-{[(2s)-2-amino-1-hydroxypropylidene]amino}-3-[(1r,2s)-2-{[(2r,3s)-3-[(2s)-butan-2-yl]-1,2-dihydroxy-4-methoxy-4-oxobutylidene]amino}cyclopropyl]propanoic acid
2-(7,8-dihydroxy-4,8-dimethylnon-3-en-1-yl)-2-methyl-6h-chromeno[6,7-c]pyrrole-5,8-diol
(1r,2r,4s,5r,7r,8r,9r,10r,13r,16s,17r)-11-ethyl-4,16-dihydroxy-13-methyl-6-methylidene-11-azahexacyclo[7.7.2.1⁵,⁸.0¹,¹⁰.0²,⁸.0¹³,¹⁷]nonadecan-7-yl acetate
(3s,3ar,4s,6as,11s,12r,15ar)-1,11,12-trihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h-cycloundeca[d]isoindol-15-one
(1r,5r,8r,10r,11r,12s,14s,16r,17r)-7-(2-hydroxyethyl)-5-methyl-13-methylidene-9-oxa-7-azahexacyclo[8.6.2.2¹¹,¹⁴.0¹,⁸.0⁵,¹⁷.0¹¹,¹⁶]icosan-12-yl acetate
anti-isorhynchophylline n-oxide
{"Ingredient_id": "HBIN016374","Ingredient_name": "anti-isorhynchophylline n-oxide","Alias": "anti-isorhynchophyllinen-oxide","Ingredient_formula": "C22H29N2O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30613;1458","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}